Trial Profile
An investigation of the effects of intranasal oxytocin on socio-emotional brain regions in Huntingtons disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 25 Jul 2018
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 19 Jul 2018 Status changed from recruiting to discontinued.
- 01 Jul 2016 New trial record